OP
CELU icon

Omni Partners’s Celularity CELU Stock Holding History

Omni Partners’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$1.84M Buy
18,237
+4,065
+29% +$417K 0.09% 116
2020
Q4 		$1.56M Sell
14,172
-11,044
-44% -$1.17M 0.09% 139
2020
Q3 		$2.65M Buy
25,216
+835
+3% +$86.5K 0.19% 86
2020
Q2 		$2.49M Sell
24,381
-619
-2% -$61.4K 0.29% 40
2020
Q1 		$2.45M Buy
+25,000
New +$2.47M 0.22% 52

Other funds holding CELU

GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $3.04B AUM 26.78% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

Omni Partners's CELU Position: Q1 2021 in Review

Omni Partners increased its Celularity (CELU) stake by 29% in Q1 2021, buying an estimated $417K and bringing the position to 18,237 shares worth $1.84M. The position accounts for 0.09% of the portfolio, ranked #116.

Omni Partners first reported a position in CELU in Q1 2020 and has held it in 5 quarters since. The position peaked at $2.65M in Q3 2020. 63 funds tracked by Wall St. Rank hold CELU as of Q1 2021.

  • Omni Partners held 18,237 shares of Celularity worth $1.84M as of Q1 2021.
  • Omni Partners bought 4,065 Celularity shares in Q1 2021, an estimated $417K.
  • Celularity made up 0.09% of Omni Partners's portfolio in Q1 2021, its #116 holding.
  • Omni Partners first reported a position in Celularity in Q1 2020 and has held it in 5 quarters since.
  • Omni Partners's Celularity position peaked at $2.65M in Q3 2020.
  • 63 funds tracked by Wall St. Rank held Celularity as of Q1 2021.

Based on Omni Partners's 13F filing for Q1 2021, filed 17 May 2021.